M&A

Shionogi aims to buy tobacco giant's pharma unit for $1bn
Pharmaphorum
Thu, 05/8/25 - 10:53 am
Shionogi
M&A
Torli Pharma
Japan Tobacco
Government cuts could help spark surge in M&A activity
Fierce Pharma
Fri, 05/2/25 - 10:43 am
M&A
Donald Trump
FTC
layoffs
Concentra acquires struggling small-molecule biotech Kronos
Fierce Biotech
Thu, 05/1/25 - 10:16 pm
Concerta
Kronos Bio
M&A
Sanofi nets €10B from Opella stake sale, eyes more 'bolt-on' deals
Fierce Pharma
Wed, 04/30/25 - 11:47 pm
Sanofi
consumer health
Opella
M&A
Novartis pays $800M upfront to buy Regulus for phase 3-ready kidney drug
Fierce Biotech
Wed, 04/30/25 - 11:37 pm
Novartis
Regulus
M&A
kidney disease
Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?
Motley Fool
Wed, 04/30/25 - 11:00 am
Pfizer
obesity
PF-07976016
M&A
Viking Therapeutics
Altimmune
Germany’s Merck KGaA in $3.9 billion deal to buy US biotech firm SpringWorks
Investing.com
Mon, 04/28/25 - 09:37 am
Merck KGaA
M&A
SpringWorks Therapeutics
Germany's Merck says in late-stage discussions to buy SpringWorks for $3.5 billion
Yahoo/Reuters
Thu, 04/24/25 - 09:12 pm
Merck KGaA
SpringWorks Therapeutics
M&A
Bluebird, after exploring 2nd buyout offer, sticks with Carlyle and SK Capital deal
Fierce Pharma
Wed, 04/16/25 - 11:40 am
Bluebird Bio
M&A
private equity
Carlyle
SK Capital
Norgine strengthens rare disease portfolio with acquisition of Theravia
Yahoo Finance
Wed, 04/16/25 - 11:18 am
M&A
Theravia
Norgine
Rare Diseases
‘Chaos’ in the biotech market has dampened hopes of a rebound. What does that mean for dealmaking and IPOs?
Pharma Voice
Tue, 04/15/25 - 09:54 am
biotech
biotech stocks
tariffs
M&A
IPOs
Theratechnologies in talks with anonymous potential buyer while fielding Future Pak buyout offer
BioSpace
Mon, 04/14/25 - 11:01 am
M&A
Theratechnologies
Future Pak
Vanda Pharmaceuticals
Keros Therapeutics stock jumps on strategic review, potential sale
Investing.com
Thu, 04/10/25 - 11:25 am
Keros Therapeutics
M&A
TGF-ß
M&A recap: Big pharma starts the year mostly avoiding billion-dollar deals
BioPharma Dive
Fri, 04/4/25 - 11:26 am
M&A
Big Pharma
JNJ
Intra-Cellular Therapies
IDRx
GSK
Novartis
Anthos Therapeutics
Eargo, Hearx merge into one OTC hearing aid firm, receive $100M boost
Medtech Dive
Fri, 04/4/25 - 10:59 am
Eargo
Hearx
LXE Hearing
hearing aids
M&A
Bluebird bio receives rival M&A bid worth 50% higher than Carlyle-SK offer
Fierce Pharma
Sun, 03/30/25 - 10:27 pm
Bluebird Bio
M&A
Ayrmid
Alcon Buys Majority Stake in Aurion to Advance Eye Disease Treatment
Morningstar
Wed, 03/26/25 - 10:19 pm
Alcon
Aurion Biotech
cell therapy
M&A
eye diseases
Mira seeks to buy Skny for its preclinical obesity, smoking cessation asset
Fierce Biotech
Mon, 03/24/25 - 11:08 am
Mira Pharmaceuticals
M&A
Skny Pharmaceuticals
obesity
smoking cessation
Chimerix engaged with 7 other biopharmas before choosing Jazz’s $935M deal—here’s why it won
Fierce Biotech
Sun, 03/23/25 - 11:45 pm
Jazz Pharma
Chimerix
M&A
Sanofi to acquire Dren Bio’s immunology unit
Investing.com
Thu, 03/20/25 - 11:25 am
Sanofi
Dren Bio
immunology
DR-0201
M&A
autoimmune diseases

Pages